Ligand validation:6D7U

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 6D7U designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6D7U_NAG_B_201	41%	77%	0.173	0.887	0.38	0.53	-	-	0	0	100%	0.9333
6D7U_NAG_C_402	36%	34%	0.132	0.821	0.6	1.95	-	4	0	0	100%	0.9333
6D7U_NAG_F_201	27%	70%	0.174	0.821	0.44	0.71	-	1	0	0	100%	0.9333
6D7U_NAG_D_201	27%	80%	0.213	0.86	0.34	0.5	-	-	0	0	100%	0.9333
6D7U_NAG_C_401	24%	74%	0.201	0.828	0.19	0.81	-	1	0	0	100%	0.9333
6D7U_NAG_A_401	16%	60%	0.251	0.819	0.25	1.27	-	1	0	0	100%	0.9333
6D7U_NAG_E_401	12%	60%	0.259	0.802	0.49	1.03	-	-	5	0	93%	0.9333
6D7U_NAG_A_402	11%	47%	0.233	0.749	0.48	1.52	-	3	0	0	100%	0.9333
6D7U_NAG_E_402	9%	58%	0.221	0.712	0.37	1.2	-	1	0	0	100%	0.9333
4KOL_NAG_B_501	84%	79%	0.098	0.959	0.29	0.56	-	-	1	0	100%	0.9333
4LKJ_NAG_B_501	77%	68%	0.112	0.951	0.51	0.73	-	-	1	0	100%	0.9333
6IDZ_NAG_B_201	72%	80%	0.114	0.936	0.31	0.52	-	-	0	0	100%	0.9333
4LKG_NAG_D_601	62%	70%	0.13	0.921	0.52	0.62	-	-	0	0	100%	0.9333
4KON_NAG_B_501	61%	60%	0.149	0.938	0.51	0.99	-	1	2	0	100%	0.9333
1OC7_NAG_A_500	100%	60%	0.04	0.991	0.61	0.9	-	1	0	0	100%	0.9333
1OC6_NAG_A_500	100%	67%	0.041	0.988	0.46	0.8	-	1	0	0	100%	0.9333
1UWC_NAG_A_262	100%	54%	0.046	0.99	0.83	0.93	-	-	0	0	100%	0.9333
6ZE6_NAG_B_703	100%	52%	0.044	0.984	0.78	1.07	-	2	0	0	100%	0.8667
6ZE2_NAG_B_704	99%	56%	0.042	0.979	0.73	0.95	-	1	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.